Accumulating evidence proved that deregulated BCL2 family expression is not provided to occur only in the tumorigenesis stage of cancer but can be observed in all stages of cancer progression, including metastasis and even in the anticancer therapeutic resistance stage.36, 37, 38. The gene discussed is BCL2; the disease is cancer.